In vivo, 2OHOA downregulates furin activity in GBM cell lines after 1 h of treatment, with a stronger concentration-dependent effect on U-87 MG cells after 48 h treatment, while the effect was independent of dose in U-118 MG cells. Here, FURIN is linked to glioblastoma.